Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Antibiotic Management for Infected Subungual Hematoma

Initial Management

  • For a subungual hematoma with signs of infection, first-line treatment should be amoxicillin-clavulanic acid or cloxacillin, with drainage of the hematoma as the primary intervention, as recommended by the Infectious Diseases Society of America 1, 2
  • If signs of infection are present, antibiotic therapy should be initiated after drainage, according to the Clinical Infectious Diseases guidelines 3, 1

Antibiotic Selection for Infected Subungual Hematoma

  • Amoxicillin-clavulanic acid is a first-line option, providing coverage against both Staphylococcus aureus and Streptococcus species, the most common pathogens in skin and soft tissue infections, as stated by the Clinical Microbiology and Infection guidelines 1, 2, 4
  • Cloxacillin is effective against methicillin-susceptible S. aureus (MSSA), which is a common pathogen in these infections, according to the Clinical Microbiology and Infection guidelines 1, 2
  • Clindamycin is effective against most community-acquired MRSA and MSSA, as recommended by the Clinical Infectious Diseases guidelines 5, 6
  • Trimethoprim-sulfamethoxazole is effective against MRSA but has less activity against streptococci, according to the Clinical Infectious Diseases guidelines 5, 6
  • Doxycycline is an alternative for MRSA coverage in adults and children over 8 years, as stated by the Clinical Infectious Diseases guidelines 5, 6

Treatment Duration and Approach

  • For mild infections with minimal systemic symptoms, a 5-day course of antibiotics is typically sufficient, as recommended by the Clinical Infectious Diseases guidelines 5
  • Treatment should be extended if the infection has not improved within this time period, according to the Clinical Infectious Diseases guidelines 5
  • If there are signs of severe infection, more aggressive antibiotic therapy may be needed, as stated by the Clinical Infectious Diseases guidelines 7

Special Considerations

  • If the patient has diabetes or is immunocompromised, consider broader antibiotic coverage and longer duration of therapy, as recommended by the Clinical Microbiology and Infection guidelines 2
  • For severe infections or those not responding to oral antibiotics, intravenous therapy may be necessary, according to the Clinical Infectious Diseases guidelines 5
  • Obtain cultures if the infection is severe, not responding to initial therapy, or in immunocompromised patients, as stated by the Clinical Infectious Diseases guidelines 5

Common Pitfalls to Avoid

  • Inappropriate antibiotic selection should be avoided, considering local resistance patterns when selecting empiric antibiotics, as recommended by the Clinical Microbiology and Infection guidelines 1, 2